Bérengère Vire

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

Yair Herishanu, Patricia Pérez‐Galán, Delong Liu et al. · Blood · 2010 · 815 citations

Medicine, Molecular Biology, Oncology +16

Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia

Georg Aue, Ndegwa Njuguna, Xin Tian et al. · Haematologica · 2009 · 94 citations · Full text

Life Sciences, Immunology, Pharmacology +17

TOSO, the Fcμ Receptor, Is Highly Expressed on Chronic Lymphocytic Leukemia B Cells, Internalizes upon IgM Binding, Shuttles to the Lysosome, and Is Downregulated in Response to TLR Activation

Bérengère Vire, Alexandre David, Adrian Wiestner · The Journal of Immunology · 2011 · 71 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia

Georg Aue, Margaret A. Lindorfer, Paul V. Beum et al. · Haematologica · 2009 · 47 citations · Full text

Medicine, Immunology, Oncology +12

Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer

Alexandre Prieur, Monica Cappellini, Guillaume Habif et al. · Clinical Cancer Research · 2017 · 42 citations

Medicine, Oncology, Pharmacology +17